Stock Scorecard
Stock Summary for Revolution Medicines Inc (RVMD) - $39.53 as of 9/2/2025 9:47:07 PM EST
Total Score
6 out of 30
Safety Score
47 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for RVMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RVMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RVMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RVMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RVMD (47 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RVMD
Financial Details for RVMD
Company Overview |
|
|---|---|
| Ticker | RVMD |
| Company Name | Revolution Medicines Inc |
| Country | USA |
| Description | Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 39.53 |
| Price 4 Years Ago | 25.17 |
| Last Day Price Updated | 9/2/2025 9:47:07 PM EST |
| Last Day Volume | 2,522,166 |
| Average Daily Volume | 1,850,780 |
| 52-Week High | 62.40 |
| 52-Week Low | 29.17 |
| Last Price to 52 Week Low | 35.52% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 37.47 |
| Sector PE | 61.24 |
| 5-Year Average PE | -10.49 |
| Free Cash Flow Ratio | 18.39 |
| Industry Free Cash Flow Ratio | 20.46 |
| Sector Free Cash Flow Ratio | 30.67 |
| Current Ratio Most Recent Quarter | 11.79 |
| Total Cash Per Share | 2.15 |
| Book Value Per Share Most Recent Quarter | 9.98 |
| Price to Book Ratio | 3.81 |
| Industry Price to Book Ratio | 7.18 |
| Sector Price to Book Ratio | 26.75 |
| Price to Sales Ratio Twelve Trailing Months | 9,035.10 |
| Industry Price to Sales Ratio Twelve Trailing Months | 51.99 |
| Sector Price to Sales Ratio Twelve Trailing Months | 13.15 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 186,933,000 |
| Market Capitalization | 7,389,461,490 |
| Institutional Ownership | 104.31% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -37.52% |
| Reported EPS 12 Trailing Months | -4.52 |
| Reported EPS Past Year | -2.44 |
| Reported EPS Prior Year | -3.57 |
| Net Income Twelve Trailing Months | -812,060,000 |
| Net Income Past Year | -600,093,000 |
| Net Income Prior Year | -436,367,000 |
| Quarterly Revenue Growth YOY | -95.20% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 402,438,000 |
| Total Cash Past Year | 543,064,000 |
| Total Cash Prior Year | 696,148,000 |
| Net Cash Position Most Recent Quarter | 402,438,000 |
| Net Cash Position Past Year | 543,064,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 2,265,204,000 |
| Total Stockholder Equity Prior Year | 1,826,194,000 |
| Total Stockholder Equity Most Recent Quarter | 1,865,369,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -700,359,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -3.75 |
| Free Cash Flow Past Year | -567,744,000 |
| Free Cash Flow Prior Year | -358,301,000 |
Options |
|
| Put/Call Ratio | 1.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.12 |
| MACD Signal | -0.38 |
| 20-Day Bollinger Lower Band | 35.17 |
| 20-Day Bollinger Middle Band | 38.45 |
| 20-Day Bollinger Upper Band | 41.73 |
| Beta | 1.16 |
| RSI | 56.22 |
| 50-Day SMA | 42.40 |
| 150-Day SMA | 33.47 |
| 200-Day SMA | 30.68 |
System |
|
| Modified | 9/2/2025 10:05:18 AM EST |